Using p53 to help diagnose ovarian cancer

Using p53 to help diagnose ovarian cancer

Bibliographic Details
Main Author:	Shweta Bansal
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2012-01-01
Series:	South Asian Journal of Cancer
Online Access:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2012;volume=1;issue=2;spage=56;epage=57;aulast=Bansal

Similar Items

The role of p53 in ovarian carcinogenesis-study by antisense p53
by: Lin, chung-hong, et al.
Published: (1996)

Immunologic aspect of ovarian cancer and p53 as tumor antigen
by: van der Burg SH, et al.
Published: (2005-09-01)

The p53 family, septin scaffolds and epithelial ovarian cancer
by: Hinds, Lynsey
Published: (2013)

The prognostic value of the p53 gene expression and mutation in ovarian cancer
by: Syahrul Rauf, et al.
Published: (2009-05-01)

Expression of p53 in epithelial ovarian tumors
by: Nihad Abdul Razak Amanullah, et al.
Published: (2020-01-01)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
by: Phong Lu, et al.
Published: (2019-05-01)

Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer.
by: Eoghainín Ó hAinmhire, et al.
Published: (2014-01-01)

A cytohistological study of p53 overexpression in ovarian neoplasms
by: Monisha Choudhury, et al.
Published: (2012-01-01)

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
by: Emre Günakan, et al.
Published: (2020-07-01)

The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status
by: Mengying Wang, et al.
Published: (2017-10-01)

The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
by: Pavla Brachova, et al.
Published: (2013-09-01)

Molecular characterization of an intact p53 pathway subtype in high-grade serous ovarian cancer.
by: Takahide Hayano, et al.
Published: (2014-01-01)

The role of ovarian hormones in p53-mediated resistance to mammary tumorigenesis
by: Dunphy, Karen A
Published: (2008)

Physical and functional interaction of p53 and p110α and implications in ovarian carcinogenesis
by: Astanehe, Arezoo
Published: (2009)

UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis
by: Zhu Q, et al.
Published: (2020-12-01)

Inverse relationship between TCTP/RhoA and p53/ /cyclin A/actin expression in ovarian cancer cells Inverse relationship between TCTP/RhoA and p53/ /cyclin A/actin expression in ovarian cancer cells
by: Malgorzata Kloc, et al.
Published: (2012-10-01)

Expression signatures of <it>TP53 </it>mutations in serous ovarian cancers
by: Murphy Susan K, et al.
Published: (2010-05-01)

TP53 polymorphisms and haplotypes in breast, cervical and ovarian cancer
by: Gornall, Robert J.
Published: (2000)

Women’s experiences with ovarian cancer: Reflections on being diagnosed
by: Margaret I. Fitch, et al.
Published: (2002-07-01)

A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
by: Ketaki Kar, et al.
Published: (2021-02-01)

p53 Signaling in Cancers
by: Natalia Issaeva
Published: (2019-03-01)

Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.
by: Bridget A Quinn, et al.
Published: (2009-12-01)

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma
by: Huang Su-Cheng, et al.
Published: (2009-12-01)

In vitro studies of p53 and cisplatin-resistance in human ovarian carcinoma cells
by: Vasey, Paul A.
Published: (1996)

Regulation of p53 by Mdm4 and ovarian hormones in mouse mammary glands
by: Lu, Shaolei
Published: (2006)

Mutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells
by: Ji-Hye Ahn, et al.
Published: (2017-08-01)

LncRNA GClnc1 may contribute to the progression of ovarian cancer by regulating p53 signaling pathway
by: Hu Li, et al.
Published: (2020-11-01)

p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides
by: Zhang Y, et al.
Published: (2021-01-01)

Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
by: Katherine Redd Bowman, et al.
Published: (2019-04-01)

Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer
by: Chae Young Han, et al.
Published: (2021-07-01)

Women Diagnosed with Ovarian Cancer: Patient and Carer Experiences and Perspectives
by: Boban S, et al.
Published: (2021-02-01)

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
by: Michalis Liontos, et al.
Published: (2020-08-01)

Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer
by: - -
Published: (2019-06-01)

Outcomes for Epithelial Ovarian Cancers Diagnosed with Concomitant Venous Thromboembolism
by: Hurtt, Callie
Published: (2016)

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers
by: Junko Umeda, et al.
Published: (2013-01-01)

USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells
by: Achuth Padmanabhan, et al.
Published: (2018-03-01)

A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin
by: Xinli Guo, et al.
Published: (2020-06-01)

Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
by: Mahsa Alaee, et al.
Published: (2016-01-01)

Epithelial ovarian cancer : influence of polymorphism at the glutathione - s - transferase GSTM1 and GSTT1 loci on expression of P53
by: Sarhanis, P.
Published: (1996)

Targeting P53 family in cancer: search for inhibitors of the P53/P73 interaction with MDMs
by: Helena Isabel Nogueira Ramos Rocha
Published: (2019)